ERYPO
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ERYPO, covering 2018-02-05 to 2018-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients [Phase 3]